Cargando…
Pentoxifylline therapy among preterm neonates <1,500 g in reducing mortality from neonatal sepsis: a double-blind, randomized placebo-controlled trial
Autores principales: | Sareno, Jessamine C, Mantaring, Jacinto Blas V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953243/ http://dx.doi.org/10.1186/cc12914 |
Ejemplares similares
-
Pentoxifylline in severe sepsis: a double-blind, randomized placebo-controlled study
por: Staubach, KH, et al.
Publicado: (1998) -
Clinical and echocardiographic characteristics associated with the evolution of the ductus arteriosus in the neonate with birth weight lower than 1,500g
por: Visconti, Luiza Fortunato, et al.
Publicado: (2013) -
Protocol: Pentoxifylline optimal dose finding trial in preterm neonates with suspected late onset sepsis (PTX-trial)
por: Kurul, Serife, et al.
Publicado: (2021) -
Reducing preterm mortality in eastern Uganda: the impact of introducing low-cost bubble CPAP on neonates <1500 g
por: Okello, F., et al.
Publicado: (2019) -
Transfusion support in preterm neonates <1500 g and/or <32 weeks in a tertiary care center: A descriptive study
por: Shanmugha Priya, R. A., et al.
Publicado: (2018)